Carbon-based nanomaterials such as single-walled carbon nanotubes and reduced graphene oxide are currently being evaluated for biomedical applications including in vivo drug delivery and tumor imaging. Several reports have studied the toxicity of carbon nanomaterials, but their effects on human male reproduction have not been fully examined. Additionally, it is not clear whether the nanomaterial exposure has any effect on sperm sorting procedures used in clinical settings. Here, we show that the presence of functionalized single walled carbon nanotubes (SWCNT-COOH) and reduced graphene oxide at concentrations of 1-25 μg/mL do not affect sperm viability. However, SWCNT-COOH generate significant reactive superoxide species at a higher concentration (25 μg/mL), while reduced graphene oxide does not initiate reactive species in human sperm. Further, we demonstrate that exposure to these nanomaterials does not hinder the sperm sorting process, and microfluidic sorting systems can select the sperm that show low oxidative stress post-exposure.
Detecting and quantifying biomarkers and viruses in biological samples have broad applications in early disease diagnosis and treatment monitoring. We have demonstrated a label-free optical sensing mechanism using nanostructured photonic crystals (PC) to capture and quantify intact viruses (HIV-1) from biologically relevant samples. The nanostructured surface of the PC biosensor resonantly reflects a narrow wavelength band during illumination with a broadband light source. Surface-adsorbed biotarget induces a shift in the resonant Peak Wavelength Value (PWV) that is detectable with <10 pm wavelength resolution, enabling detection of both biomolecular layers and small number of viruses that sparsely populate the transducer surface. We have successfully captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads ranging from 10(4) to 10(8) copies/mL. The surface density of immobilized biomolecular layers used in the sensor functionalization process, including 3-mercaptopropyltrimethoxysilane (3-MPS), N-gamma-Maleimidobutyryl-oxysuccinimide ester (GMBS), NeutrAvidin, anti-gp120, and bovine serum albumin (BSA) were also quantified by the PC biosensor.
On page 2553, U. Demirci and co-workers address the need for clinical HIV-I detection at the acute stage, where antibodies are present in very low concentrations. Their fast and extremely affordable portable diagnostic tool allows on-chip virus detection without the need for any labeling steps. Through impedance analysis, the device can sense the unique electrical signature of the viral nano-lysates. This means that the tool is also highly selective, could be easily extended for use in detecting other infectious diseases, and could even be adapted to detect multiple diseases at the same time.
Detecting acute Human Immunodeficiency Virus (HIV-1) at the point-of-care (POC) is an unmet clinical need. Current POC detection methods such as dipsticks and OraQuick detect antibodies and not the intact virus. These methods are not effective due the low concentration of antibodies [1, 2]. Infected persons with acute HIV-1 can potentially transmit the infection because they are not aware of their disease [3, 4]. Rapid and inexpensive POC detection diagnostic tool to detect acute HIV-1 can potentially have a substantial effect on preventing HIV-1 transmission through people at high risk of HIV-1.
Abstract Development of portable biosensors has broad applications in environmental monitoring, clinical diagnosis, public health, and homeland security. There is an unmet need for pathogen detection at the point‐of‐care (POC) using a fast, sensitive, inexpensive, and easy‐to‐use method that does not require complex infrastructure and well‐trained technicians. For instance, detection of Human Immunodeficiency Virus (HIV‐1) at acute infection stage has been challenging, since current antibody‐based POC technologies are not effective due to low concentration of antibodies. In this study, we demonstrated for the first time a label‐free electrical sensing method that can detect lysed viruses, i.e. viral nano‐lysate, through impedance analysis, offering an alternative technology to the antibody‐based methods such as dipsticks and Enzyme‐linked Immunosorbent Assay (ELISA). The presented method is a broadly applicable platform technology that can potentially be adapted to detect multiple pathogens utilizing impedance spectroscopy for other infectious diseases including herpes, influenza, hepatitis, pox, malaria, and tuberculosis. The presented method offers a rapid and portable tool that can be used as a detection technology at the POC in resource‐constrained settings, as well as hospital and primary care settings.
Abstract The need for sensitive, robust, portable and inexpensive biosensing platforms is of significant interest in clinical applications for disease diagnosis and treatment monitoring at the point-of-care (POC) settings. Rapid, accurate POC diagnostic assays play a crucial role in developing countries, where there are limited laboratory infrastructure, trained personnel and financial support. However, current diagnostic assays commonly require long assay time, sophisticated infrastructure and expensive reagents that are not compatible with resource-constrained settings. Although paper and flexible material-based platform technologies provide alternative approaches to develop POC diagnostic assays for broad applications in medicine, they have technical challenges integrating to different detection modalities. Here, we address the limited capability of current paper and flexible material-based platforms by integrating cellulose paper and flexible polyester films as diagnostic biosensing materials with various detection modalities through the development and validation of new widely applicable electrical and optical sensing mechanisms using antibodies and peptides. By incorporating these different detection modalities, we present selective and accurate capture and detection of multiple biotargets including viruses (Human Immunodeficieny Virus-1), bacteria ( Escherichia coli and Staphylococcus aureus) and cells (CD4 + T lymphocytes) from fingerprick volume equivalent of multiple biological specimens such as whole blood, plasma and peritoneal dialysis effluent with clinically relevant detection and sensitivity.
